[1] 中华医学会神经病学分会神经遗传学组,中国医师协会神经内科医师分会神经遗传学组.中国发作性运动诱发性运动障碍诊治指南[J].中华神经科杂志,2022,55(1):9-14.
[2] Mounir Alaoui O, Charbonneau P F, Prin P, et al. TMEM151A as an alternative to PRRT2 inparoxysmal kinesigenic dyskinesia: about three new cases[J]. Parkinsonism Relat Disord,2023, 108: 105295.
[3] Li H F, Chen Y L, Zhuang L, et al. TMEM151A variants cause paroxysmal kinesigenic dyskinesia[J]. Cell Discov,2021,7(1):83.
[4] Chen Y L, Chen D F, Li H F, et al. Features differ between paroxysmal kinesigenic dyskinesia patients with PRRT2 and TMEM151A variants[J]. Mov Disord,2022,37(3):608-613.
[5] Tian W T, Zhan F X, Liu Z H, et al. TMEM151A variants cause paroxysmal kinesigenic dyskinesia: a large-sample study[J].Mov Disord,2022,37(3):545-552.
[6] Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied[J].Neurology,1967,17(7):680-690.
[7] Xu J J, Li H F, Wu Z Y.P aroxysmal kinesigenic dyskinesia: genetics and pathophysiological mechanisms[J]. Neurosci Bull,2024,40(7):952-962.
[8] Bhatia K P . Paroxysmal dyskinesias[J]. Mov Disord, 2011,26(6):1157-1165.
[9] Huang X J, Wang S G, Guo X N, et al. The phenotypic and genetic spectrum of paroxysmal kinesigenic dyskinesia in China[J]. Mov Disord, 2020, 35(8): 1428-1437.
[10] Gardella E, Becker F, Moller R S, et al. Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation[J].Ann Neurol,2016,79(3):428-436.
[11] Tian W T, Huang X J, Mao X, et al. Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia: clinical and genetic analyses of 163 patients[J].Mov Disord,2018,33(3):459-467.
[12] Liao J, Salles P, Shuaib U, et al. Genetic updates on paroxysmal dyskinesias[J].J Neural Transm (Vienna),2021,128(4):447-471.
[13] Jiang Y, Yuan F, Yang Y, et al. CHRNA4 variant causes paroxysmal kinesigenic dyskinesia and genetic epilepsy with febrile seizures plus?[J].Seizure,2018,56:88-91.
[14] Yin X, Lin J, Cao L, et al. Familial paroxysmal kinesigenic dyskinesia is associated with mutations in the KCNA1 gene[J].Hum Mol Genet,2018,27(4):625-637.
[15] Huang X J, Fu X, Wu J Y, et al. Heterozygous KCNJ10 variants affecting Kir4.1 channel cause paroxysmal kinesigenic dyskinesia[J].Mov Disord, 2024,39(12):2199-2210.
[16] Ebrahimi-Fakhari D, Saffari A, Westenberger A, et al. The evolving spectrum of PRRT2-associated paroxysmal diseases[J]. Brain, 2015,138(Pt 12):3476-3495.
[17] Fruscione F, Valente P, Sterlini B, et al. PRRT2 controls neuronal excitability by negatively modulating Na+channel 1.2/1.6 activity[J]. Brain, 2018,141(4):1000-1016.
[18] Tan G H, Liu Y Y, Wang L, et al. PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum[J].Cell Res, 2018,28(1):90-110.
[19] Zhang W, Li S S, Han Y, et al. Sex differences in electrophysiological properties of mouse medial preoptic area neurons revealed by in vitro whole-cell recordings[J]. Neurosci Bull,2021,37(2): 166-182.
[20] Dibué M, Kamp M A, Alpdogan S, et al. Cav2.3 (R-Type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo[J].Cell Physiol Biochem,2017,44 (3): 935-947.
[21] Tian W T, Huang X J, Mao X, et al. Depression, anxiety, and quality of life in paroxysmal kinesigenic dyskinesia patients[J].Chin Med J,2017,130(17):2088-2094.
[22] Ekmen A, Doulazmi M, Méneret A, et al. Non-Motor symptoms and quality of life in patients with PRRT2-related paroxysmal kinesigenic dyskinesia[J].Mov Disord Clin Pract,2023,10(7):1082-1089.